| Autor: |
Sergio Raposeiras-Roubín, José Ramón González Juanatey, Gaetano M. De Ferrari, José P.S. Henriques, Laura Montagna, Iván J. Núñez-Gil, Tim Kinnaird, Lazar Velicki, Alessandro Durante, Shaoping Nie, Tetsuma Kawaji, Ferdinando Varbella, Xiantao Song, Matteo Bianco, Masa-aki Kawashiri, Alicia Quirós, Fabrizio D'Ascenzo, Umberto Morbiducci, Christoph Liebetrau, Fabrizio Ugo, Alessia Luciano, Stephen B. Wilton, Alessandro Careggio, Paola Destefanis, Amanda Spirito, Enrico Cerrato, Dimitrios Alexopoulos, Carlo Alberto Biolè, Giacomo Boccuzzi, Toshiharu Fujii, Emad Abu-Assi, Zenon Huczek, Alberto Dominguez-Rodriguez, Giorgio Quadri, Sergio Manzano-Fernández, Luis C. L. Correia, Andrea Rognoni, Christian Templin, Albert Ariza-Solé |
| Přispěvatelé: |
Cardiology, ACS - Atherosclerosis & ischemic syndromes |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 35(6), 1171-1182. Kluwer Academic Publishers |
| ISSN: |
1573-7241
0920-3206 |
| DOI: |
10.1007/s10557-021-07213-y |
| Popis: |
Purpose: Higher risk of bleeding with ticagrelor over clopidogrel in elderly patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) has been suggested. We assessed the incidence of major bleedings (MB), reinfarction (re-MI), and all-cause death to evaluate safety and efficacy of ticagrelor versus clopidogrel in such population. Methods: Real-world registries RENAMI and BleeMACS were merged. The pooled cohort was divided into two groups, clopidogrel versus ticagrelor. Statistical analysis considered patients |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink 